QPharma launches Neolytica for AI-focused analytics

By The Science Advisory Board staff writers

June 9, 2021 -- QPharma has launched Neolytica, a new subsidiary focused on artificial intelligence (AI) for healthcare analytics.

QPharma's move to invest in data analytics and AI meshes well with the company's expertise in the pharmaceutical industry, in particular key opinion leader (KOL) mapping and healthcare professional (HCP) targeting. Neolytica's analytical solutions will use next-generation technologies like natural language processing, AI, face recognition, and chatbots.

Neolytica will focus its efforts on the use of AI in medical affairs, market access, commercial marketing, and commercial sales, according to the company.

Copyright © 2021 scienceboard.net

CPhI North America
August 10-12
Philadelphia, Pennsylvania United States
Bioprocessing Summit
August 16-19
Boston, Massachusetts United States
6th Annual CAR-TCR Summit
August 30 - September 2
European Congress of Immunology (ECI) 2021
September 1-4
Belgrade Serbia
Medical Affairs Strategic Summit (MASS)
September 13-15
New Brunswick, New Jersey United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter